The nurse is assessing a preterm infant. to what does the infant’s level of maturation refer?

1. Harris S. Hyperinsulinism and dysinsulinism. JAMA 1924;83:729-33. 10.1001/jama.1924.02660100003002 [CrossRef] [Google Scholar]

2. Hypoglycemia Hartmann A. J Pediatr 1998;132:1-3. 10.1016/S0022-3476(98)70474-3 [PubMed] [CrossRef] [Google Scholar]

3. Cornblath M, Ichord R. Hypoglycemia in the neonate. Semin Perinatol 2000;24:136-49. 10.1053/sp.2000.6364 [PubMed] [CrossRef] [Google Scholar]

4. Heck LJ, Erenberg A. Serum glucose levels in term neonates during the first 48 hours of life. J Pediatr 1987;110:119-22. 10.1016/S0022-3476(87)80303-7 [PubMed] [CrossRef] [Google Scholar]

5. Committee on Fetus and Newborn , Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 2011;127:575-9. 10.1542/peds.2010-3851 [PubMed] [CrossRef] [Google Scholar]

6. Lubchenco LO, Bard H. Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age. Pediatrics 1971;47:831-8. [PubMed] [Google Scholar]

7. Parmelee AH, Jr, Minkowski A, Saint-Anne Dargassies S, et al. Neurological evaluation of the premature infant. A follow-up study. Biol Neonate 1970;15:65-78. 10.1159/000240212 [PubMed] [CrossRef] [Google Scholar]

8. Duvanel CB, Fawer CL, Cotting J, et al. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr 1999;134:492-8. 10.1016/S0022-3476(99)70209-X [PubMed] [CrossRef] [Google Scholar]

9. Gutberlet RL, Cornblath M. Neonatal hypoglycemia revisited, 1975. Pediatrics 1976;58:10-7. [PubMed] [Google Scholar]

10. Kalhan S, Peter-Wohl S. Hypoglycemia: what is it for the neonate? Am J Perinatol 2000;17:11-8. 10.1055/s-2000-7296 [PubMed] [CrossRef] [Google Scholar]

11. Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol 1989;160:385-9. 10.1016/0002-9378(89)90453-5 [PubMed] [CrossRef] [Google Scholar]

12. Bozzetti P, Ferrari MM, Marconi AM, et al. The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism 1988;37:358-63. 10.1016/0026-0495(88)90136-9 [PubMed] [CrossRef] [Google Scholar]

13. Marconi AM, Paolini C, Buscaglia M, et al. The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol 1996;87:937-42. 10.1016/0029-7844(96)00048-8 [PubMed] [CrossRef] [Google Scholar]

14. Sweet CB, Grayson S, Polak M. Management strategies for neonatal hypoglycemia. J Pediatr Pharmacol Ther 2013;18:199-208. 10.5863/1551-6776-18.3.199 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

15. Thompson-Branch A, Havranek T. Neonatal Hypoglycemia. Pediatr Rev 2017;38:147-57. 10.1542/pir.2016-0063 [PubMed] [CrossRef] [Google Scholar]

16. de Lonlay P, Giurgea I, Touati G, et al. Neonatal hypoglycaemia: aetiologies. Semin Neonatol 2004;9:49-58. 10.1016/j.siny.2003.08.002 [PubMed] [CrossRef] [Google Scholar]

17. Schwitzgebel VM, Gitelman SE. Neonatal hyperinsulinism. Clin Perinatol 1998;25:1015-38. [PubMed] [Google Scholar]

18. Vannucci RC, Vannucci SJ. Glucose metabolism in the developing brain. Semin Perinatol 2000;24:107-15. 10.1053/sp.2000.6361 [PubMed] [CrossRef] [Google Scholar]

19. Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr 2015;167:238-45. 10.1016/j.jpeds.2015.03.057 [PubMed] [CrossRef] [Google Scholar]

20. Hay WW., Jr Placental-fetal glucose exchange and fetal glucose metabolism. Trans Am Clin Climatol Assoc 2006;117:321-39. [PMC free article] [PubMed] [Google Scholar]

21. Simmons RA. Cell glucose transport and glucose handling during fetal and neonatal development. In: Polin RA, Fox WW, Abman SH. editors. Fetal and Neonatal Physiology. 4th Ed. Philadelphia: Elsevier (Saunders), 2011:560-6. [Google Scholar]

22. Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab 1993;77:1554-62. [PubMed] [Google Scholar]

23. Arnott G, Coghill G, McArdle HJ, et al. Immunolocalization of GLUT1 and GLUT3 glucose transporters in human placenta. Biochem Soc Trans 1994;22:272S. 10.1042/bst022272s [PubMed] [CrossRef] [Google Scholar]

24. Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 2010;298:E141-5. 10.1152/ajpendo.00712.2009 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

25. Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab 1999;84:695-701. [PubMed] [Google Scholar]

26. Jansson T, Wennergren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol 1999;180:163-8. 10.1016/S0002-9378(99)70169-9 [PubMed] [CrossRef] [Google Scholar]

27. Kainulainen H, Jarvinen T, Heinonen PK. Placental glucose transporters in fetal intrauterine growth retardation and macrosomia. Gynecol Obstet Invest 1997;44:89-92. 10.1159/000291493 [PubMed] [CrossRef] [Google Scholar]

28. Xing AY, Challier JC, Lepercq J, et al. Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. J Clin Endocrinol Metab 1998;83:4097-101. [PubMed] [Google Scholar]

29. Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol 2012;39:769-83. 10.1016/j.clp.2012.09.009 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

30. Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med 2005;10:341-50. 10.1016/j.siny.2005.04.001 [PubMed] [CrossRef] [Google Scholar]

31. Srinivasan G, Pildes RS, Cattamanchi G, et al. Plasma glucose values in normal neonates: a new look. J Pediatr 1986;109:114-7. 10.1016/S0022-3476(86)80588-1 [PubMed] [CrossRef] [Google Scholar]

32. Hume R, Burchell A, Williams FL, et al. Glucose homeostasis in the newborn. Early Hum Dev 2005;81:95-101. 10.1016/j.earlhumdev.2004.10.005 [PubMed] [CrossRef] [Google Scholar]

33. Hume R, Pazouki S, Hallas A, et al. The ontogeny of the glucose-6-phosphatase enzyme in human embryonic and fetal red blood cells. Early Hum Dev 1995;42:85-95. 10.1016/0378-3782(95)01626-E [PubMed] [CrossRef] [Google Scholar]

34. Midgley PC, Russell K, Oates N, et al. Activity of the adrenal fetal zone in preterm infants continues to term. Endocr Res 1996;22:729-33. 10.1080/07435809609043769 [PubMed] [CrossRef] [Google Scholar]

35. Doerr HG, Sippell WG, Versmold HT, et al. Plasma mineralocorticoids, glucocorticoids, and progestins in premature infants: longitudinal study during the first week of life. Pediatr Res 1988;23:525-9. 10.1203/00006450-198805000-00018 [PubMed] [CrossRef] [Google Scholar]

36. Scott SM, Watterberg KL. Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants. Pediatr Res 1995;37:112-6. 10.1203/00006450-199501000-00021 [PubMed] [CrossRef] [Google Scholar]

37. De León DD, Stanley CA. Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3:57-68. 10.1038/ncpendmet0368 [PubMed] [CrossRef] [Google Scholar]

38. Cornblath M, Hawdon JM, Williams AF, et al. Controversies Regarding Definition of Neonatal Hypoglycemia: Suggested Operational Thresholds. Pediatrics 2000;105:1141-5. 10.1542/peds.105.5.1141 [PubMed] [CrossRef] [Google Scholar]

39. Carmen S. Neonatal hypoglycemia in response to maternal glucose infusion before delivery. J Obstet Gynecol Neonatal Nurs 1986;15:319-23. 10.1111/j.1552-6909.1986.tb01403.x [PubMed] [CrossRef] [Google Scholar]

40. Collins JE, Leonard JV. Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet 1984;2:311-3. 10.1016/S0140-6736(84)92685-0 [PubMed] [CrossRef] [Google Scholar]

41. Whipple AO, Frantz VK. Adenoma of Islet Cells with Hyperinsulinism: A Review. Ann Surg 1935;101:1299-335. 10.1097/00000658-193506000-00001 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

42. Wackernagel D, Dube M, Blennow M, et al. Continuous subcutaneous glucose monitoring is accurate in term and near-term infants at risk of hypoglycaemia. Acta Paediatr 2016;105:917-23. 10.1111/apa.13479 [PubMed] [CrossRef] [Google Scholar]

43. Sprague JE, Arbelaez AM. Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev 2011;9:463-73. [PMC free article] [PubMed] [Google Scholar]

44. Adamkin DH. Neonatal hypoglycemia. Curr Opin Pediatr 2016;28:150-5. 10.1097/MOP.0000000000000319 [PubMed] [CrossRef] [Google Scholar]

45. Rozance PJ, Hay WW., Jr New approaches to management of neonatal hypoglycemia. Matern Health Neonatol Perinatol 2016;2:3. 10.1186/s40748-016-0031-z [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Marles SL, Casiro OG. Persistent neonatal hypoglycemia: Diagnosis and management. Paediatr Child Health 1998;3:16-9. 10.1093/pch/3.1.16 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

47. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Validation of the continuous glucose monitoring sensor in preterm infants. Arch Dis Child Fetal Neonatal Ed 2013;98:F136-40. 10.1136/archdischild-2012-301661 [PubMed] [CrossRef] [Google Scholar]

48. McGowan JE, Perlman JM. Glucose management during and after intensive delivery room resuscitation. Clin Perinatol 2006;33:183-96. 10.1016/j.clp.2005.11.007 [PubMed] [CrossRef] [Google Scholar]

49. Belik J, Musey J, Trussell RA. Continuous infusion of glucagon induces severe hyponatremia and thrombocytopenia in a premature neonate. Pediatrics 2001;107:595-7. 10.1542/peds.107.3.595 [PubMed] [CrossRef] [Google Scholar]

50. Bhowmick SK, Lewandowski C. Prolonged hyperinsulinism and hypoglycemia. In an asphyxiated, small for gestation infant. Case management and literature review. Clin Pediatr (Phila) 1989;28:575-8. 10.1177/000992288902801205 [PubMed] [CrossRef] [Google Scholar]

51. Lindley KJ, Dunne MJ, Kane C, et al. Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child 1996;74:373-8. 10.1136/adc.74.5.373 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Wasserman DH, Spalding JA, Lacy DB, et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 1989;257:E108-17. [PubMed] [Google Scholar]

53. Carter PE, Lloyd DJ, Duffty P. Glucagon for hypoglycaemia in infants small for gestational age. Arch Dis Child 1988;63:1264-6. 10.1136/adc.63.10.1264 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

54. McMahon AW, Wharton GT, Thornton P, et al. Octreotide use and safety in infants with hyperinsulinism. Pharmacoepidemiol Drug Saf 2017;26:26-31. 10.1002/pds.4144 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

55. Virgili N, Mancera P, Wappenhans B, et al. K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation. PLoS One 2013;8:e75189. 10.1371/journal.pone.0075189 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

56. Touati G, Poggi-Travert F, Ogier de Baulny H, et al. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 1998;157:628-33. 10.1007/s004310050900 [PubMed] [CrossRef] [Google Scholar]

57. Durmaz E, Flanagan SE, Parlak M, et al. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant. J Clin Res Pediatr Endocrinol 2014;6:119-21. 10.4274/jcrpe.1230 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

58. Baş F, Darendeliler F, Demirkol D, et al. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 1999;12:873-8. 10.1515/JPEM.1999.12.6.873 [PubMed] [CrossRef] [Google Scholar]

59. Weston PJ, Harris DL, Harding JE. Dextrose gel treatment does not impair subsequent feeding. Arch Dis Child Fetal Neonatal Ed 2017. [Epub ahead of print]. [PubMed] [Google Scholar]

60. Ter M, Halibullah I, Leung L, et al. Implementation of dextrose gel in the management of neonatal hypoglycaemia. J Paediatr Child Health 2017;53:408-11. 10.1111/jpc.13409 [PubMed] [CrossRef] [Google Scholar]

61. Rawat M, Chandrasekharan P, Turkovich S, et al. Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia. Biomed Hub 2016;1. pii: 448511. [PMC free article] [PubMed]

62. Hegarty JE, Harding JE, Gamble GD, et al. Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study). PLoS Med 2016;13:e1002155. 10.1371/journal.pmed.1002155 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

63. Harris DL, Alsweiler JM, Ansell JM, et al. Outcome at 2 Years after Dextrose Gel Treatment for Neonatal Hypoglycemia: Follow-Up of a Randomized Trial. J Pediatr 2016;170:54-9.e1. 10.1016/j.jpeds.2015.10.066 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

64. Harris DL, Weston PJ, Signal M, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet 2013;382:2077-83. 10.1016/S0140-6736(13)61645-1 [PubMed] [CrossRef] [Google Scholar]

65. Vannucci RC, Vannucci SJ. Hypoglycemic brain injury. Semin Neonatol 2001;6:147-55. 10.1053/siny.2001.0044 [PubMed] [CrossRef] [Google Scholar]

66. Anderson LR, Bass AR. Some effects of victory or defeat upon perception of political candidates. J Soc Psychol 1967;73:227-40. 10.1080/00224545.1967.9712460 [PubMed] [CrossRef] [Google Scholar]

67. Volpe JJ. Hypoglycemia and brain injury. In: Volpe JJ. editor. Neurology of the Newborn. Philadelphia: Saunders, 2001:97-520. [Google Scholar]

68. Auer RN. Hypoglycemic brain damage. Forensic Sci Int 2004;146:105-10. 10.1016/j.forsciint.2004.08.001 [PubMed] [CrossRef] [Google Scholar]

69. Koivisto M, Blanco-Sequeiros M, Krause U. Neonatal symptomatic and asymptomatic hypoglycaemia: a follow-up study of 151 children. Dev Med Child Neurol 1972;14:603-14. 10.1111/j.1469-8749.1972.tb02642.x [PubMed] [CrossRef] [Google Scholar]

70. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 1988;297:1304-8. 10.1136/bmj.297.6659.1304 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

71. Filan PM, Inder TE, Cameron FJ, et al. Neonatal hypoglycemia and occipital cerebral injury. J Pediatr 2006;148:552-5. 10.1016/j.jpeds.2005.11.015 [PubMed] [CrossRef] [Google Scholar]

72. Burns CM, Rutherford MA, Boardman JP, et al. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008;122:65-74. 10.1542/peds.2007-2822 [PubMed] [CrossRef] [Google Scholar]

73. Per H, Kumandas S, Coskun A, et al. Neurologic sequelae of neonatal hypoglycemia in Kayseri, Turkey. J Child Neurol 2008;23:1406-12. 10.1177/0883073808319075 [PubMed] [CrossRef] [Google Scholar]

74. Montassir H, Maegaki Y, Ogura K, et al. Associated factors in neonatal hypoglycemic brain injury. Brain Dev 2009;31:649-56. 10.1016/j.braindev.2008.10.012 [PubMed] [CrossRef] [Google Scholar]

75. Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, et al. Neonatal Morbidities and Developmental Delay in Moderately Preterm-Born Children. Pediatrics 2012;130:e265-72. 10.1542/peds.2012-0079 [PubMed] [CrossRef] [Google Scholar]

76. Tin W, Brunskill G, Kelly T, et al. 15-year follow-up of recurrent “hypoglycemia” in preterm infants. Pediatrics 2012;130:e1497-503. 10.1542/peds.2012-0776 [PubMed] [CrossRef] [Google Scholar]

77. McKinlay CJ, Alsweiler JM, Ansell JM, et al. Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years. N Engl J Med 2015;373:1507-18. 10.1056/NEJMoa1504909 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

78. Kaiser JR, Bai S, Gibson N, et al. Association Between Transient Newborn Hypoglycemia and Fourth-Grade Achievement Test Proficiency: A Population-Based Study. JAMA Pediatr 2015;169:913-21. 10.1001/jamapediatrics.2015.1631 [PubMed] [CrossRef] [Google Scholar]

79. Harris DL, Weston PJ, Williams CE, et al. Cot-side electroencephalography monitoring is not clinically useful in the detection of mild neonatal hypoglycemia. J Pediatr 2011;159:755-60.e1. 10.1016/j.jpeds.2011.04.026 [PubMed] [CrossRef] [Google Scholar]

80. Cummins CJ, Lust WD, Passonneau JV. Regulation of glycogenolysis in transformed astrocytes in vitro. J Neurochem 1983;40:137-44. 10.1111/j.1471-4159.1983.tb12663.x [PubMed] [CrossRef] [Google Scholar]

81. Edmond J, Robbins RA, Bergstrom JD, et al. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 1987;18:551-61. 10.1002/jnr.490180407 [PubMed] [CrossRef] [Google Scholar]

82. Hack M, Breslau N, Weissman B, et al. Effect of very low birth weight and subnormal head size on cognitive abilities at school age. N Engl J Med 1991;325:231-7. 10.1056/NEJM199107253250403 [PubMed] [CrossRef] [Google Scholar]

83. Sexson WR. Incidence of neonatal hypoglycemia: a matter of definition. J Pediatr 1984;105:149-50. 10.1016/S0022-3476(84)80382-0 [PubMed] [CrossRef] [Google Scholar]

84. Williams AF. Hypoglycaemia of the newborn: a review. Bull World Health Organ 1997;75:261-90. [PMC free article] [PubMed] [Google Scholar]

Page 2

Causes of hypoglycemia (15,19,42)